Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ContextVision ABOSL:CONTX +1.18%82 3-1 Month Momentum % is -6.69% as of Aug. 02, 2026. GuruFocus rates OSL:CONTX with a GF Score™ of 82/100 and a GF Value™ of kr5.10 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 677 Healthcare Providers & Services companies, ContextVision AB ranks worse than 59.08% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-02), ContextVision AB's 3-1 Month Momentum % is -6.69%.
The industry rank for ContextVision AB's 3-1 Month Momentum % or its related term are showing as below:
OSL:CONTX's 3-1 Month Momentum % is ranked worse than 59.08% of 677
companies
in the Healthcare Providers & Services industry
Industry Median: -3.1
vs OSL:CONTX: -6.69
ContextVision AB (OSL:CONTX) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
ContextVision AB 3-1 Month Momentum % Related Terms
OSL:CONTX vs VEEV, BTSG, HQY: 3-1 Month Momentum % Comparison
For the Health Information Services subindustry, ContextVision AB's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ContextVision AB 3-1 Month Momentum % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, ContextVision AB's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where ContextVision AB's 3-1 Month Momentum % falls into.
ContextVision AB (OSL:CONTX) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ContextVision AB (OSL:CONTX) has a 3-1 Month Momentum % of -6.69% as of Aug. 02, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on ContextVision AB and its competitors. According to the industry distribution chart, ContextVision AB ranks #400 out of 677 companies in the Healthcare Providers & Services industry, placing it in the top 59.1%.
Is ContextVision AB's 3-1 Month Momentum % too high?
ContextVision AB's current 3-1 Month Momentum % is -6.69%. Based on the distribution chart, ContextVision AB ranks #400 out of 677 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, ContextVision AB has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ContextVision AB's 3-1 Month Momentum % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, ContextVision AB ranks #400 out of 677 companies for 3-1 Month Momentum %. This places ContextVision AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Healthcare Providers & Services company?
A good 3-1 Month Momentum % depends on the Healthcare Providers & Services industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on ContextVision AB and its competitors. ContextVision AB's current 3-1 Month Momentum % is -6.69%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ContextVision AB stock overvalued right now?
Based on GuruFocus' analysis, ContextVision AB (OSL:CONTX) is currently considered Significantly Undervalued. The stock's GF Value™ is kr5.10, compared to a current price of kr3.44 — trading 32.5% below its estimated fair value. The current 3-1 Month Momentum % is -6.69%. ContextVision AB's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For ContextVision AB (OSL:CONTX), the current 3-1 Month Momentum % is -6.69% as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ContextVision AB (OSL:CONTX) Overvalued in 2026?
Based on GuruFocus' analysis, ContextVision AB stock appears to be undervalued.
The current stock price of kr3.44 is trading 32.5% below its estimated GF Value™ of kr5.10.
GuruFocus considers ContextVision AB to be Significantly Undervalued.
Key valuation signals for OSL:CONTX:
3-1 Month Momentum %: -6.69%
GF Value™: kr5.10 vs. price of kr3.44 (32.5% below fair value)
No single metric tells the full story. See the OSL:CONTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ContextVision AB is a medical technology company. It develops and sells image enhancement software for medical diagnosis and artificial intelligence. Its product portfolio includes image enhancement software for 2D/3D/4D (dimensional) ultrasound, magnetic resonance imaging (MRI), X-Ray, radiography, and mammography. Its geographical segments are Asia, Europe, and America.
82GF Score
Get the complete analysis for OSL:CONTX
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSL:CONTX has been successfully added to your 
